Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

214
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
214
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

276
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
276
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

200
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
200
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

261
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
261

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Xuanfei Baidu decoction alleviates intestinal inflammation and modulates microbiota distribution by suppressing IMD/NF-κB and JNK signaling pathways.

Frontiers in microbiology·2026
Same author

Effects of pressure versus volume controlled ventilation on postoperative pulmonary complications during elderly trendelenburg laparoscopic surgery.

Scientific reports·2026
Same author

From Ambient Assistance to Data-Driven Precision in AI-Enabled Alzheimer's Care (2004-2025): A Bibliometric Perspective.

The Gerontologist·2026
Same author

Landscape of T-cell bispecific antibodies in cancer therapy: therapeutic strategies, challenges and future prospection.

Molecular cancer·2026
Same author

Publisher Correction: Multi-ancestry genome-wide association analyses of refractive error augment genetic discovery and polygenic prediction.

Nature genetics·2026
Same author

A novel β-cyclodextrin-based chiral stationary phase for enantioseparation and evaluation of paclobutrazol enantioselective degradation and bioaccumulation in a soil-earthworm system.

Journal of chromatography. B, Analytical technologies in the biomedical and life sciences·2026
Same journal

Understanding the Added Value of Action Limits for QTL Monitoring.

Therapeutic innovation & regulatory science·2026
Same journal

Implementing Project Optimus in Oncology Dosage Optimization: Where are We Now?

Therapeutic innovation & regulatory science·2026
Same journal

Validation of the Ontario Protocol Assessment Level (OPAL) Tool for Assessing Clinical Trial Complexity and Supporting Workforce Planning in the Italian Clinical Research Context.

Therapeutic innovation & regulatory science·2026
Same journal

The Effect of Covariate Adjustment for Cox Regression in Cardiovascular Outcome Trials.

Therapeutic innovation & regulatory science·2026
Same journal

Current Status and Construction Requirements of Drug Clinical Trial Institutions in Sichuan Province in China.

Therapeutic innovation & regulatory science·2026
Same journal

The CARE Program: An Initiative of Patient-Focused Drug Development for Rare Diseases by NMPA.

Therapeutic innovation & regulatory science·2026
See all related articles

Related Experiment Video

Updated: Jan 24, 2026

Guidelines for Elective Pediatric Fiberoptic Intubation
11:19

Guidelines for Elective Pediatric Fiberoptic Intubation

Published on: January 17, 2011

18.5K

Pharmacometrics in Pediatrics.

Xiaoxi Liu1, Robert M Ward1

  • 11 Department of Pediatrics, Division of Clinical Pharmacology, University of Utah, Salt Lake City, UT, USA.

Therapeutic Innovation & Regulatory Science
|May 30, 2019
PubMed
Summary
This summary is machine-generated.

Pharmacometrics, including population pharmacokinetics, offer advanced insights but require specialized training. Clearer publications are needed for pediatric clinicians to effectively use these complex analyses.

Keywords:
clinical pediatricsnonlinear mixed effects modelingpediatric clinical trialspediatric pharmacokineticspopulation pharmacokinetics

More Related Videos

Evaluating the Effects of Different Polishing Methods on Color Stability of Dental Restorations in Pediatric Dentistry
03:37

Evaluating the Effects of Different Polishing Methods on Color Stability of Dental Restorations in Pediatric Dentistry

Published on: June 6, 2025

410
Author Spotlight: Simulating Pediatric Cardiac Surgery Using a Neonatal Piglet Model
04:55

Author Spotlight: Simulating Pediatric Cardiac Surgery Using a Neonatal Piglet Model

Published on: May 26, 2023

1.3K

Related Experiment Videos

Last Updated: Jan 24, 2026

Guidelines for Elective Pediatric Fiberoptic Intubation
11:19

Guidelines for Elective Pediatric Fiberoptic Intubation

Published on: January 17, 2011

18.5K
Evaluating the Effects of Different Polishing Methods on Color Stability of Dental Restorations in Pediatric Dentistry
03:37

Evaluating the Effects of Different Polishing Methods on Color Stability of Dental Restorations in Pediatric Dentistry

Published on: June 6, 2025

410
Author Spotlight: Simulating Pediatric Cardiac Surgery Using a Neonatal Piglet Model
04:55

Author Spotlight: Simulating Pediatric Cardiac Surgery Using a Neonatal Piglet Model

Published on: May 26, 2023

1.3K

Area of Science:

  • Pharmacometrics
  • Clinical Pharmacology
  • Pediatric Drug Development

Background:

  • Pharmacometrics has evolved significantly, incorporating complex mathematical models like population pharmacokinetics.
  • These advanced methods analyze drug disposition (clearance, volume of distribution) and covariate effects, particularly useful in small pediatric populations.

Purpose of the Study:

  • To highlight the gap in training and understanding of advanced pharmacometric analyses among pediatric clinicians.
  • To emphasize the need for accessible publications detailing these methods for clinical application.

Main Methods:

  • Review of current pharmacometric methodologies, including noncompartmental and population pharmacokinetic analyses.
  • Discussion of the application and interpretation of results, including fixed and variable effects and error measures.

Main Results:

  • Advanced pharmacometric analyses provide valuable data but are underutilized by clinicians due to training deficits.
  • Clinicians struggle to interpret complex results and assess patient population representation in studies.

Conclusions:

  • There is a critical need for improved educational resources and clearer publications on pharmacometrics for pediatric clinicians.
  • Enhanced understanding will facilitate better application of these powerful analytical tools in pediatric patient care.